Literature DB >> 9334567

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry.

M Dulcan.   

Abstract

These practice parameters review the literature on children, adolescents, and adults with attention-deficit/hyperactivity disorder (ADHD). There are three types of ADHD: predominantly inattentive, predominantly hyperactive-impulsive, and combined. Together, they occur in as many as 10% of boys and 5% of girls of elementary school age. Prevalence declines with age, although up to 65% of hyperactive children are still symptomatic as adults. Frequency in adults is estimated to be 2% to 7%. Assessment includes clinical interviews and standardized rating scales from parents and teachers. Testing of intelligence and academic achievement usually are required. Comorbidity is common. The cornerstones of treatment are support and education of parents, appropriate school placement, and pharmacology. The primary medications are psychostimulants, but antidepressants and alpha-adrenergic agonists are used in special circumstances. Other treatments such as behavior modification, school consultation, family therapy, and group therapy address remaining symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334567     DOI: 10.1097/00004583-199710001-00007

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  110 in total

1.  Evidence and belief in ADHD.

Authors:  M Zwi; P Ramchandani; C Joughin
Journal:  BMJ       Date:  2000-10-21

Review 2.  Evidence based management of attention deficit hyperactivity disorder.

Authors:  J P Guevara; M T Stein
Journal:  BMJ       Date:  2001-11-24

Review 3.  Attention deficit hyperactivity disorder.

Authors:  J P Guevara; M T Stein
Journal:  West J Med       Date:  2001-09

Review 4.  Evidence-based treatment for mental disorders in children and adolescents.

Authors:  Gregory A Fabiano; William E Pelham
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

5.  Help-seeking steps and service use for children in foster care.

Authors:  B T Zima; R Bussing; X Yang; T R Belin
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

6.  The role of primary care physicians in attention-deficit/hyperactivity disorder.

Authors:  Laurel K Leslie
Journal:  Pediatr Ann       Date:  2002-08       Impact factor: 1.132

Review 7.  Areas for future investment in the field of ADHD: preschoolers and clinical networks.

Authors:  Manfred Döpfner; Aribert Rothenberger; Edmund Sonuga-Barke
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

8.  Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder.

Authors:  David W Goodman
Journal:  P T       Date:  2010-05

9.  Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.

Authors:  John S Markowitz; Arthur B Straughn; Kennerly S Patrick; C Lindsay DeVane; Linda Pestreich; James Lee; Yanfeng Wang; Rafael Muniz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 10.  Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Authors:  M Cyr; C S Brown
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.